Imagine a 3D printer that can build a large metal part and then instantly switch to a microscopic needle to carve invisible patterns or add 'smart' coatings. It's like having a giant construction crane and a jeweler's tool in one single machine. This allows parts to do things like fix themselves when they break or release medicine exactly where it's needed.
Manufacturing high-value components currently relies on fragmented production chains and geometry-driven designs, leading to long lead times and an inability to integrate micro-scale smart functions into macro-scale parts.
A TRL7 multi-process machine combining macro-scale DED with micro/nano-scale laser ablation, 2PP, and DALP. It includes modular heads for rapid switching between additive and subtractive processes.
If you are an implant manufacturer dealing with high rejection risks in spinal surgeries — this project developed a spinal cage prosthesis that uses triggered biomolecule diffusion to enhance healing and reduce rejection.
If you are a jet engine component producer dealing with turbine blade corrosion — this project developed a machine that creates blades with self-healing coatings to improve durability and resistance.
If you are an infrastructure operator dealing with pipeline leaks — this project developed a self-repairing patch for hydroelectric pipelines to reduce maintenance downtime.
Based on available project data, specific pricing or cost figures for the machine are not provided.
Yes, the machine achieves deposition rates up to 500 cm³/h and is designed to reach TRL9 for commercial launch within 24 months after project completion.
Based on available project data, the specific IP and licensing terms are not detailed, though the project involves a consortium of 16 partners including 8 SMEs.
The AI-driven engineering reduces design-to-manufacturing lead times by up to 30% and accelerates design adaptation by 50%.
The system integrates multiple processes (DED, laser ablation, 2PP, DALP) into a single platform, replacing fragmented production chains.
The consortium is heavily industry-weighted with 11 industrial partners (69% ratio), including 8 SMEs, which indicates a strong focus on commercialization rather than pure research. With 16 partners across 7 countries, the group combines high-end mechatronics and laser physics expertise to move a TRL5 technology toward a TRL9 commercial product.
Contact ALTFORM S.R.L. in Italy for technical specifications and commercialization timelines.
Contact us to identify potential licensing opportunities for this multi-process manufacturing technology.
